EICHORCondition: Solid Tumor, Adult · Sponsor: Kumquat Biosciences Inc.
The goal of this clinical trial is to learn if KQB198 works to treat advanced solid tumor cancer in adults. It will also learn about the safety of KQB198. The main questions it aims to answer are: * What is the safe dose of KQB198 by itself or in combination with other anti-cancer drugs? * Does KQB198 alone or in combination with other anti-cancer drugs decrease the size of the tumor? * What happens to KQB198 in the body? Participants will: * Take KQB198 daily, alone or in combination with another anti-cancer drug * Visit the clinic about 8 times in the first 8 weeks, and then once every 4 weeks after that
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Sarah Cannon Research Institute at HealthONE | Denver, Colorado, United States | — |
| Sarah Cannon Research Institute at Florida Cancer Specialists - Lake Nona - | Orlando, Florida, United States | — |
| Florida Cancer Specialists - Sarasota | Sarasota, Florida, United States | — |
| Henry Ford Health System | Detroit, Michigan, United States | — |
| David H. Koch Center for Cancer Center at Memorial Sloan Kettering Cancer Center | Long Island City, New York, United States | — |
| The Lindner Center for Research and Education at The Christ Hospital | Cincinnati, Ohio, United States | — |
| Sarah Cannon and HCA Research Institute | Nashville, Tennessee, United States | — |
| New Experimental Therapeutics of San Antonio - NEXT Oncology | San Antonio, Texas, United States | — |
| New Experimental Therapeutics of Virginia - NEXT Oncology | Fairfax, Virginia, United States | — |
| Institut Paoli-Calmettes | Marseille, Bouches-du-Rhône, France | — |
| Institut de Cancerologie de l'Ouest - site St-Herblain | Saint-Herblain, Loire-Atlantique, France | — |
| CHU Bordeaux - Hopital Saint-Andre | Bordeaux, Nouvelle-Aquitane, France | — |
+ 14 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06507306